Travere Therapeutics TVTX
NASDAQ TVTX
$56.93 +0.08 (+0.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Other Accumulated Expenses (2012 - 2026)

Updated

Travere Therapeutics (TVTX) recorded Other Accumulated Expenses of $2.1 million in Q2 2026, down 85.3% from $14.29 million a year earlier and unchanged from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Other Accumulated Expenses (2012 - 2026) Analysis & Trends

At the end of FY2025, Travere Therapeutics reported Other Accumulated Expenses of $3.19 million, down 81.3% from FY2024.

  • Annual Other Accumulated Expenses has a five-year compound annual growth rate of -11.8% (FY2020 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $17.11 million in FY2024 (+226.6%), $5.24 million in FY2023 (-8.5%), $5.72 million in FY2022 (-7.5%) and $6.19 million in FY2021 (+3.5%).
  • Quarterly Other Accumulated Expenses has ranged from $2.1 million in Q1 2026 to $17.11 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Other Accumulated Expenses has declined for three consecutive quarters, with growth averaging 42.3% over the last eight quarters.
  • Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 226.6% in Q4 2024, against a decline of 86.7% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.1 million (Q1 2026), $3.19 million (Q4 2025) and $5.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Travere Therapeutics 5.36 Bn 4.96 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.10 Mn
Mar 31, 2026 2.10 Mn
Dec 31, 2025 3.19 Mn
Sep 30, 2025 5.35 Mn
Jun 30, 2025 14.29 Mn
Mar 31, 2025 15.76 Mn
Dec 31, 2024 17.11 Mn
Sep 30, 2024 5.23 Mn
Jun 30, 2024 5.24 Mn
Mar 31, 2024 5.43 Mn
Dec 31, 2023 5.24 Mn
Sep 30, 2023 5.24 Mn
Jun 30, 2023 5.24 Mn
Mar 31, 2023 5.73 Mn
Dec 31, 2022 5.72 Mn
Sep 30, 2022 5.72 Mn
Jun 30, 2022 6.02 Mn
Mar 31, 2022 6.06 Mn
Dec 31, 2021 6.19 Mn
Sep 30, 2021 10.06 Mn
API Access

Travere Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TVTX&period=max&api_key=YOUR_API_KEY